Droplette’s professional regenerative treatments microinfuse pharmaceutical-grade stem cell-derived growth factors, cytokines, peptides and exosomes through its patented needle-less microinfusion system (US Patent #US20170274159A1). Each two-minute treatment transforms stem cell bioactives into a high velocity mist that penetrates up to 20 cell layers deep (25um), enabling absorption of regenerative molecules previously inaccessible through noninvasive methods. Clinicians seeking to elevate healing protocols and support long-term skin health will find in these two treatments potent, pharmaceutical-grade solutions—clinically validated to enhance recovery, reduce inflammation, and maintain skin’s structural integrity and cellular function without irritation or downtime.
